No Data
No Data
Reproductive Genetics Market Analysis Report 2024-2032, Featuring Bangkok Genomics Innovation, Centogene, Fulgent Genetics, Igenomix, Invitae, PerkinElmer and Thermo Fisher Scientific
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics
Centogene (CNTG) said Tuesday it will continue to give Takeda Pharmaceutical (TAK) access to diagnostic testing for patients with Lysosomal Storage Disorders, or LSDs, under the companies' extended ag
Centogene, Takeda Extend Diagnostic Partnership
CENTOGENE and Takeda Boost Genetic Testing for LSDs
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders, Financial Terms Undisclosed
Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the extension of an ongoing partnership with Takeda (NY
CENTOGENE Collaborates On Research Published In Science Showing Immunopathological Landscape Of Human Pre-TCRα Deficiency
CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the publication in Science of research
No Data